The New Frontier of Global Demand: A Key Gateway to Dental Sleep Medicine
In the field of Obstructive Sleep Apnea (OSA), ShareSmile Biotech has entered the rapidly growing global market of Dental Sleep Medicine through its proprietary brand, OSAWELL. As aging populations, chronic sleep disorders, and the demand for interdisciplinary healthcare integration continue to rise, next-generation Oral Appliance Therapy (OAT) has become a critical treatment gateway connecting dentistry, sleep medicine, and digital healthcare — offering strong clinical demand and significant scalability potential.
ShareSmile Biotech has pioneered an innovative system integrating 3D imaging and an AI-driven treatment design engine, transforming conventional mandibular advancement device (MAD) therapy from a simple forward-positioning approach into a comprehensive 3D spatial treatment concept. The company has also invested extensively in research focused on temporomandibular joint (TMJ) asymmetric occlusal movement and dental sleep medicine.
Supported by a QMS-compliant medical manufacturing system, ShareSmile Biotech empowers clinicians to deliver highly precise, predictable, and reproducible sleep treatment solutions. Through long-term academic collaborations with leading medical universities in Taiwan and around the world, the company continues to accumulate clinical data and establish standardized treatment protocols, further strengthening trust and credibility within the industry.
Regulatory and technical information
- TFDA licence number
- 衛部醫器製字第008771號
- Device class
- Class II medical device
- Patent
- Taiwan invention patent I820560 (granted 2023, licensed from Taipei Medical University)
- R&D origin
- Developed by a Taipei Medical University cross-disciplinary team under patent licence
- Mechanism
- Based on mandibular advancement device (MAD) principles; the advancement is assessed and adjusted by a clinician for each patient
The information on this site is for reference only and does not replace professional medical diagnosis. Outcomes vary between individuals; please consult a qualified clinician.
Expert advisory board
Dr. Da Yuan Wang
Implantology, periodontics, sedation dentistry
DDS from Columbia University with a master's in nutrition and a dental degree from Taipei Medical University. Former clinical director of Columbia University's implant centre and former dean of the College of Oral Medicine at Taipei Medical University; licensed to practise dentistry in the United States.
Dr. Fei Peng Lee
Otology, paediatric ENT, head and neck surgery
Former superintendent of Shuang Ho Hospital, Wan Fang Hospital and Taipei Medical University Hospital. Professor of otolaryngology at Taipei Medical University and past president of the Taiwan Otolaryngological Society.
Dr. Chia Tze Kao
Orthodontics, paediatric dentistry, clear aligners
Professor at the College of Medicine, Chung Shan Medical University. Former vice president of the university and former head of orthodontics at its affiliated hospital.
Dr. Leopoldo P. Correa
Dental sleep medicine, MAD protocols, temporomandibular care
Former associate professor at Tufts University School of Dental Medicine and a member of the American Academy of Dental Sleep Medicine. Director of a global dental sleep medicine research programme and co-founder and co-chair of the World Dental Sleep Society, with over 20 years in the field.
Dr. Stanley Liu
OSA surgery, oral and maxillofacial surgery
Former associate professor at Stanford University and a Fellow of the American College of Surgeons. Chair of oral and maxillofacial surgery at Nova Southeastern University, a founding member of the World Dental Sleep Society, and author of more than 90 scientific papers.
Learn more:OSAWELL official siteFull OSA education, OAT versus CPAP comparison, manufacturing detail and the clinician directory
Frequently asked questions
What is OSAWELL?
OSAWELL is the ShareSmile Biotech own brand in dental sleep medicine, with products used in oral appliance therapy (OAT).
What is OAT (oral appliance therapy)?
OAT stands for Oral Appliance Therapy, a non-surgical approach in which an oral appliance is worn during sleep, applied to obstructive sleep apnoea (OSA). Whether it is suitable must be assessed individually by a qualified clinician.
How does the OSAWELL treatment design differ from a conventional MAD?
OSAWELL combines 3D imaging with an AI treatment-design engine, bringing conventional MAD (mandibular advancement device) design into three-dimensional consideration, alongside research into asymmetric temporomandibular occlusal movement and dental sleep medicine.
What academic collaborations does OSAWELL have?
ShareSmile Biotech maintains long-term academic collaborations with medical universities in Taiwan and abroad to accumulate clinical data and treatment standards, including a technology transfer with Taipei Medical University and a Memorandum of Agreement (MoA) with the University of Malaya.
Can patients buy an OSAWELL appliance directly?
No. OSAWELL is a medical device and must be assessed and prescribed by a qualified dentist. It is one supporting option within clinical assessment and application, and its benefits still require individual evaluation by a qualified clinician.